A preclinical study of allogeneic <scp>CD19</scp> chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies
Dan Wang(Peking University), Liming Yang(Hunan Children's Hospital), Jianjun Tong(Southwest Jiaotong University), Liuyang Wang(Zhejiang Medicine (China)), Zhiqiang Xiang(Beike Biotechnology (China)), Hong–Lin Zhu, Yuli Wang(Tianjin Institute of Pharmaceutical Research (China)), Qinghua Sun, Man Xu, Shuai Liu, Xiancai Li, Shuyang Wang(Northeast Petroleum University), Hengcai Wang
Cited by 2
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell Differentiation
|Immunity|2004|1.1k
Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program
|Immunity|2002|1k
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues
|Infection and Immunity|1994|157
CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET
|Journal of Experimental & Clinical Cancer Research|2020|99